AI Generated Image
Chinese stem cell therapy reverses heart failure in 90% of patients, landmark trial finds
Yahoo • • health
Key Points:
- A clinical trial in China demonstrated that a novel stem cell therapy reversed severe heart failure in 90% of treated patients by promoting new heart tissue growth and restoring cardiac function.
- The therapy involved transforming patients' own cells into induced pluripotent stem cells (iPSCs), differentiating them into heart muscle cells, and injecting them into damaged heart areas.
- Compared to a control group undergoing coronary artery bypass surgery, stem cell recipients showed significantly improved heart function, reduced symptoms, and better performance on a six-minute walking test over 12 months.
- No severe adverse events were reported, although two patients experienced temporary tachycardia that resolved within weeks, highlighting the need for further research on the therapy's risk-to-benefit profile.
- This stem cell approach offers a promising alternative to heart transplants, which are limited by donor scarcity, but additional studies are required to confirm long-term safety and efficacy.
